Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Nistala

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Diabetes|March 22, 2014
Tissue-specific expression of GLP1R in mice: is the problem of antibody nonspecificity solved?Annayya Aroor, Ravi Nistala
Current Hypertension Reports|January 29, 2014
Is there a role for the incretin system in blood pressure regulation?Akhilesh Rao, Ravi Nistala
American Journal of Physiology. Renal Physiology|January 27, 2017
Diabetes, hypertension, and chronic kidney disease progression: role of DPP4Ravi Nistala, Virginia Savin
Molecular and Cellular Endocrinology|February 19, 2013
Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin IIRavi Nistala, Adam Whaley-Connell
Journal of the Cardiometabolic Syndrome|August 7, 2007
Skeletal muscle insulin resistance is fundamental to the cardiometabolic syndromeRavi Nistala, Craig S Stump
Nature Reviews. Nephrology|November 28, 2012
Hypertension: Synergy of antihypertensives in elderly patients with CKDRavi Nistala, James R Sowers
American Journal of Hypertension|April 21, 2010
Micro vs. macrovascular reactivity in insulin resistance: the debate reignitedRavi Nistala, Adam Whaley-Connell
Nucleic Acids Research|May 10, 2002
A reliable and efficient method for deleting operational sequences in PACs and BACsRavi Nistala, Curt D Sigmund
Canadian Journal of Physiology and Pharmacology|February 9, 2017
mTORC1 inhibitors rapamycin and metformin affect cardiovascular markers differentially in ZDF ratsRavi Nistala, Ahmad Raja, Lakshmi Pulakat
Recent Patents on Cardiovascular Drug Discovery|February 18, 2010
Bioabsorbable coronary stents--are these the next big thing in coronary angioplasty?Sudarshan Balla, Kul Aggarwal, Ravi Nistala
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Diabetes|March 22, 2014
Tissue-specific expression of GLP1R in mice: is the problem of antibody nonspecificity solved?Annayya Aroor, Ravi Nistala
Current Hypertension Reports|January 29, 2014
Is there a role for the incretin system in blood pressure regulation?Akhilesh Rao, Ravi Nistala
American Journal of Physiology. Renal Physiology|January 27, 2017
Diabetes, hypertension, and chronic kidney disease progression: role of DPP4Ravi Nistala, Virginia Savin
Molecular and Cellular Endocrinology|February 19, 2013
Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin IIRavi Nistala, Adam Whaley-Connell
Journal of the Cardiometabolic Syndrome|August 7, 2007
Skeletal muscle insulin resistance is fundamental to the cardiometabolic syndromeRavi Nistala, Craig S Stump
Nature Reviews. Nephrology|November 28, 2012
Hypertension: Synergy of antihypertensives in elderly patients with CKDRavi Nistala, James R Sowers
American Journal of Hypertension|April 21, 2010
Micro vs. macrovascular reactivity in insulin resistance: the debate reignitedRavi Nistala, Adam Whaley-Connell
Nucleic Acids Research|May 10, 2002
A reliable and efficient method for deleting operational sequences in PACs and BACsRavi Nistala, Curt D Sigmund
Canadian Journal of Physiology and Pharmacology|February 9, 2017
mTORC1 inhibitors rapamycin and metformin affect cardiovascular markers differentially in ZDF ratsRavi Nistala, Ahmad Raja, Lakshmi Pulakat
Recent Patents on Cardiovascular Drug Discovery|February 18, 2010
Bioabsorbable coronary stents--are these the next big thing in coronary angioplasty?Sudarshan Balla, Kul Aggarwal, Ravi Nistala
Pageof 7